Businesstoday
HOME
ECONOMY
Additional 400 kms of dedicated freight corridors to be ready by March: Piyush Goyal
Tamil Nadu textile firms seek govt help to tap man-made fibre clothing segment
SC upholds 100-homebuyer threshold for insolvency application against realtors
Jan Dhan accounts cross 41 crore, only 7.5% zero-balance accounts
India to supply COVID-19 vaccines to 6 partner nations from Wednesday
CORPORATE
Tata Trusts B2B app to let businesses buy directly from artisans
ICICI Lombard Q3 results: Profit jumps 6.6% to Rs 314 crore on equity market rally
SEC approves Phase 1 trial of Bharat Biotech's COVID-19 nasal vaccine
Radha Dhir to succeed Ramesh Nair as JLL India CEO
Tata Communications Q3 results: Profit jumps over 5-fold to Rs 309 crore on lower costs
MARKETS
Indiabulls Real Estate share rises over 12% post Q3 earnings
Sensex, Nifty rebound after two days of correction: Five factors behind the rally
Investor wealth rises by Rs 3.43 lakh crore as Sensex, Nifty log best gain in four months
Maruti Suzuki share rises over 2% as firm announces price hike
YES Bank share rises for second session, here's why
MONEY
BT Insight: How to save long-term capital gains on equity mutual funds
IRDAI asks insurers to forge agreements on COVID-19 treatment rates
BT Buzz: How to vaccinate against Bitcoin fever
Life insurance sector's new premium biz falls 3% in Dec
MF investors pull out over Rs 16,000 crore from equity, hybrid schemes in Dec
INDUSTRY
Serum Institute releases advisory on COVID-19 vaccine; things to know before taking Covishield
Travel, tourism jobs are back; 20.7 million employed in Dec quarter: CMIE
Pakistan approves Sinopharm's COVID-19 jab for emergency use
COVID-19 vaccination: World on brink of catastrophic moral failure, says WHO chief
WHO close to sealing Pfizer deal to give poorer countries access to vaccines
TECH
MeitY to establish Quantum Computing Applications Lab in collaboration with AWS
Poco F2 may launch as a high-end smartphone as Poco India country director dismiss rumours of a mid-range SoC
Qualcomm announces Snapdragon 870 SoC for affordable premium phones, 5G supported
Canon, Sony dominate latest BCN Japanese market share report
PhonePe beats Google Pay again to become top UPI mobile app in December
OPINION
Budget 2021: 3 ways govt can increase retail participation in bond market
From response to recovery: How COVID-19 crisis spurred turnaround of microfinance industry
Budget 2021: Infra push can boost economy, improve competitiveness
Rebooting Economy 59: Quantum jump in fiscal spending is what India needs immediately
Digital lending: Now more than ever we need fintechs to democratise credit, uplift livelihoods
photos
Vaccination drive in India: Here is what we know so far
SIP, FPI, FII: What dominated equity inflows in 2020?
Budget 2021 round the corner: Everything you should know
AUMs of Indian MF industry reach all-time high
A look at New Delhi Railway Station after redevelopment
Videos
09:02
We will see more people migrating to Signal from WhatsApp: Aruna Harder
16:46
Experts discuss ways by which govt could spur growth of the economy
03:13
Turnout dips on day 3 of vaccination; Jobs in Japan for Indians
10:39
Covid cess or tax deduction? What Budget 2021 has in store for taxpayers
04:07
There has been a shift from quantity to quality education: Rajiv Kumar
MAGAZINE
January 24, 2021
January 10, 2021
December 27, 2020
December 13, 2020
November 29, 2020
Settings
Logout
BT SPECIALS
SPECIAL ISSUES
SPECIAL REPORTS
BT BUZZ
SLOWDOWN BLUES
JOBS REALITY CHECK
UNION BUDGET
WORLD ECONOMIC FORUM
LOK SABHA ELECTION 2019
REBRAIN OR ROT
EVENTS
MAGAZINE ARCHIVES
BUSINESS TODAY
MONEY TODAY
GADGETS AND GIZMOS
Home
Search
Total 354 results found. Search for
[ drug pricing ]
Results 1 to 21 of 354
Covishield to cost Rs 219-292 to govt; Rs 438-584 in private market: SII CEO Adar Poonawalla
BusinessToday.In
January 4, 2021
SII CEO Adar Poonawalla said that the company will start selling the Covishield to the Indian government and GAVI (Global Alliance for Vaccines and Immunisation) nations in the first stage, followed by the private market
COVID-19 vaccine will be 'little to no out-of-pocket costs' for Indians, says Pfizer
BusinessToday.In
December 17, 2020
Pfizer's statement has come after several reports have surfaced which indicated that the government wouldn't be procuring the Pfizer-BioNTech vaccine because of its high cost and the extreme cold chain requirement of -70 degree Celsius
India prepares for 60 crore COVID-19 vaccines; to use standard cold storage
Reuters
December 12, 2020
India readies for 60 crore doses of Covid-19 vaccines to be administered to the most vulnerable people through conventional cold chain systems, says top government expert
Pfizer's coronavirus vaccine price may differ depending on country's GDP
BusinessToday.In
December 9, 2020
Albert Bourla, the CEO of Pfizer, said the company will have tiered pricing for the middle-income countries (including, India) and will give the vaccine free in Africa
Share Market Highlights: Sensex ends at record high, Nifty at 13,529; Infosys, ITC, RIL top performers
BusinessToday.In
December 9, 2020
India Stock Market Highlights Today: Intraday, both indices touched all time highs today, with Sensex hitting 46,164 and Nifty touching 13,548.
Pfizer addresses storage concerns; explains how storing at -70 degree Celsius will take place
BusinessToday.In
December 7, 2020
Pfizer's clarification comes as experts believe that storing the vaccine in minus 70 degree Celsius would be a big hurdle
COVID-19 vaccine: What is emergency authorisation and why it is not for the masses?
BusinessToday.In
November 27, 2020
After the publication of early data from phase-3 clinical trials, drugmakers Pfizer and BioNTech have sought regulatory approval to deploy their inoculation under emergency-use rules. American biotech company Moderna is also likely to do the same soon
AstraZeneca's COVID vaccine efficacy unclear; emergency approval likely by Jan: Nomura
BusinessToday.In
November 25, 2020
Indian drug regulator may provide an emergency approval to AstraZeneca's COVID-19 vaccine by end-December or early January 21, says Nomura
India may get Oxford University's coronavirus vaccine in Jan-Feb
BusinessToday.In
November 23, 2020
Coronavirus vaccine update: Adar Poonawalla, the CEO of Serum Institute had recently said that his company might sell a two-shot COVID-19 vaccine for around Rs 500-600 for the general public
Coronavirus vaccine update: Bharat Biotech's Covaxin launch likely in Q2 of 2021, no word on pricing yet
BusinessToday.In
November 22, 2020
Bharat Biotech has started the phase- 3 trial of its potential COVID-19 vaccine, involving 26,000 volunteers this month across 25 centres in the country, including Hyderabad, Goa, Nagpur, Bhubaneswar, and Aligarh
Mankind Pharma to help doctors create their own virtual clinic
PB Jayakumar
September 2, 2020
Mankind has been promoting DrOnA Health among doctors as a service to help them. Over 10,000 doctors are now using the facility. Another special feature of the app is that it allows doctors to have complete ownership of data.
Zydus Cadila's Remdesivir at Rs 2,800 cheapest so far; triggers price war in COVID-19 treatment
PB Jayakumar
August 13, 2020
Remdesivir price: Zydus is the fifth Indian company to launch the drug for coronavirus treatment after Hetero Labs, Cipla, Mylan NV and Jubilant Life Sciences. Priced at Rs 2,800 for a 100 mg lyophilized injection, its brand 'Remdac' will be the most economical
Domestic pharmaceutical industry to grow at 8-11% CAGR in FY 2020-23: ICRA
PB Jayakumar
August 6, 2020
Though margins remain healthy, pricing pressures for the US base generics business, lack of limited competition products and manufacturing quality issues will continue to trouble them, said ICRA
Coronavirus treatment: Favipiravir leads to price war among pharma companies in India
BusinessToday.In
July 26, 2020
Coronavirus drug: Jenburkt Pharmaceuticals is the latest company to roll out Favipiravir for Rs 39 per tablet - its cheapest pricing yet
Coronavirus Vaccine News Live Updates: Can turmeric treat COVID-19, research shows it has antiviral properties
BusinessToday.In
July 24, 2020
Coronavirus (Covid-19) Vaccine News Latest Updates: The study showed that curcumin can prevent Transmissible gastroenteritis virus (TGEV)- an alpha-group coronavirus that infects pigs, from infecting cells. The higher doses of curcumin were also found to kill virus particles
Glenmark says FabiFlu shows positive results in Phase 3; mild, moderate COVID-19 cases improved faster
BusinessToday.In
July 22, 2020
Coronavirus treatment: Patients who were administered Glenmark's FabiFlu saw 40 per cent faster achievement of clinical cure
FabiFlu 'cheapest' COVID-19 drug; Glenmark calls overpricing charge baseless
PB Jayakumar
July 21, 2020
Glenmark says compared to other therapies approved for emergency use in COVID-19 in India, FabiFlu is much more economical and an effective treatment option; DCGI had earlier asked it to clarify on allegation that the drug was unaffordable due to its high pricing
Coronavirus drug: Glenmark defends FabiFlu pricing after DGCI notice
Reuters
July 21, 2020
\"Compared to other therapies approved for emergency use in COVID-19, FabiFlu is much more economical and an effective treatment option,\" the company said in a statement to the exchanges
Coronavirus: New studies clarify what drugs help, hurt COVID-19 treatment
Associated Press
July 20, 2020
For months before studies like these, learning what helps or harms has been undermined by \"desperation science\" as doctors and patients tried therapies on their own or through a host of studies not strong enough to give clear answers
Sun Pharma aims to gain market share in all verticals amid COVID-19 pandemic
PTI
July 19, 2020
The drug major, which has presence in around 150 countries, caters to various various segments like psychiatry, anti-infectives, neurology, cardiology, oncology, among others
PAGES 1 OF 18
1
2
3
4
5
Advertisement
LATEST
Must Read
TECH NEWS
Additional 400 kms of dedicated freight corridors to be ready by March: Piyush Goyal
Tamil Nadu textile firms seek govt help to tap man-made fibre clothing segment
Tata Trusts B2B app to let businesses buy directly from artisans
SC upholds 100-homebuyer threshold for insolvency application against realtors
ICICI Lombard Q3 results: Profit jumps 6.6% to Rs 314 crore on equity market rally
More
Reliance Jio Prime vs Airtel, Vodafone, Idea 4G offers
Reliance Jio plans to bring 5G internet to your smartphones
Maruti Suzuki opens online booking for Baleno RS
India Inc to get 9.5 per cent salary hike this year
Five tips to get a good salary hike this year
Poco F2 may launch as a high-end smartphone as Poco India country director dismiss rumours of a mid-range SoC
Canon, Sony dominate latest BCN Japanese market share report
Qualcomm announces Snapdragon 870 SoC for affordable premium phones, 5G supported
PhonePe beats Google Pay again to become top UPI mobile app in December
Sale on OnePlus phones and TVs back this Republic Day, OnePlus 8T 5G available for Rs 38,999
More